A detailed history of Hrt Financial LP transactions in Volitionrx LTD stock. As of the latest transaction made, Hrt Financial LP holds 16,569 shares of VNRX stock, worth $5,467. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,569
Previous 11,993 38.16%
Holding current value
$5,467
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$0.6 - $0.78 $2,745 - $3,569
4,576 Added 38.16%
16,569 $11,000
Q2 2025

Aug 14, 2025

BUY
$0.42 - $0.92 $5,037 - $11,033
11,993 New
11,993 $9,000
Q4 2021

Feb 14, 2022

SELL
$3.02 - $4.13 $198,021 - $270,804
-65,570 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.98 - $3.48 $8,931 - $10,429
2,997 Added 4.79%
65,570 $203,000
Q2 2021

Aug 16, 2021

BUY
$3.01 - $3.78 $188,344 - $236,525
62,573 New
62,573 $205,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $18.9M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.